| 1 | [SID103186571] | Active | IC50 | 2.1 | Inhibition of [3H]GABA binding to Gamma-aminobutyric acid A (GABA-A) receptor of rat brain membranes [AID72319, Type: Literature] | |   View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 103186571 | | CID | 763 | | Outcome | Active | | IC50 | 2.1 [uM] | | BioAssay | Inhibition of [3H]GABA binding to Gamma-aminobutyric acid A (GABA-A) receptor of rat brain membranes | | AID | 72319 | | BioAssay type | Literature | | Target | | | PubMed | 3027337 | | Data Table | |
|
| 2 | [SID103186571] | Unspecified | Ki | 1500 | Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting [AID630741, Type: Literature] | | View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103186571 | | CID | 763 | | Outcome | Unspecified | | Ki | 1500 [uM] | | BioAssay | Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting | | AID | 630741 | | BioAssay type | Literature | | Target | | | PubMed | 21955456 | | Data Table | |
|
| 3 | [SID103186571] | Unspecified | | | Percentage inhibition against tryptase at 10 uM [AID243684, Type: Literature] | Tryptase alpha/beta-1 [gi:18202508] | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103186571 | | CID | 763 | | Outcome | Unspecified | | BioAssay | Percentage inhibition against tryptase at 10 uM | | AID | 243684 | | BioAssay type | Literature | | Target | Tryptase alpha/beta-1 [gi:18202508] | | PubMed | 15745817 | | Data Table | |
|
| 4 | [SID103186571] | Unspecified | | | In vivo blood glucose was determined in obese, hyperglycemic, hyperinsulinemic, insulin-resistant KKAy mice after a dose of 500 mg/kg for 4 days [AID94678, Type: Literature] | | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103186571 | | CID | 763 | | Outcome | Unspecified | | BioAssay | In vivo blood glucose was determined in obese, hyperglycemic, hyperinsulinemic, insulin-resistant KKAy mice after a dose of 500 mg/kg for 4 days | | AID | 94678 | | BioAssay type | Literature | | Target | | | PubMed | 11312922 | | Data Table | |
|
| 5 | [SID103186571] | Unspecified | | | In vivo blood glucose was determined in obese, hyperglycemic, hyperinsulinemic, insulin-resistant KKAy mice after a dose of 500 mg/kg for 4 days [AID94679, Type: Literature] | | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103186571 | | CID | 763 | | Outcome | Unspecified | | BioAssay | In vivo blood glucose was determined in obese, hyperglycemic, hyperinsulinemic, insulin-resistant KKAy mice after a dose of 500 mg/kg for 4 days | | AID | 94679 | | BioAssay type | Literature | | Target | | | PubMed | 11312923 | | Data Table | |
|
| 6 | [SID68629] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 7 | [SID68629] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 8 | [SID68629] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 9 | [SID68629] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 10 | [SID68629] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 11 | [SID68629] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 12 | [SID68629] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 68629 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 13 | [SID132058] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 132058 | | CID | 763 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
